Related Experiment Video
Updated: Jul 9, 2026

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
Published on: May 10, 2022
Putative receptor-binding sites of hepatitis E virus
Shuizhen He1, Ji Miao1, Zizheng Zheng1
1National Institute of Diagnostics and Vaccine Development of Infectious Disease, and Research Center for Medical Molecular Virology of Fujian Province, Xiamen University, Xiamen, 361005, PR China.
Abstract:
A truncated structural protein of hepatitis E virus (HEV), p239, occurs as 23 nm particles consisting of partial homodimers. As the latter resemble the HEV capsomere structurally and antigenically, it was postulated that the recombinant protein may serve as a probe for the HEV receptor. This hypothesis was supported by findings that purified p239 bound and penetrated different cell lines that are susceptible to HEV, and inhibited HEV infection of these cells. The binding was blocked by four of six monoclonal antibodies (mAbs) reactive against the dimeric domain of p239, and by two of three mAbs reactive against its monomeric domain, suggesting that binding may involve a portion of each domain. Mutation affecting the monomeric domain had no effect on binding or capacity to block HEV infection, whereas that affecting the dimeric domain diminished binding of the mutant peptide markedly and abrogated its capacity to block HEV infection. These results suggest that HEV infection might involve distinct receptor-binding sites.
Related Concept Videos
Hepatitis
Viral Hepatitis I: Introduction
Inhibitors Of Virion Release
Coronavirus
Leaky Scanning
